What took so long?
statnews.com • • health
Key Points:
- Novo Nordisk has launched an oral version of its GLP-1 weight loss drug Wegovy, marking a significant development in obesity treatment.
- Eli Lilly's oral GLP-1 pill, orforglipron, is anticipated to receive approval as early as this month, intensifying competition in the weight loss drug market.
- Injectable GLP-1 drugs have been highly successful since their approval for obesity treatment, but the introduction of oral forms addresses previous limitations.
- The availability of effective oral GLP-1 weight loss pills fulfills a long-standing goal in the pharmaceutical industry.
